Camp4 Therapeutics

PriceCamp4 Therapeutics

CAMP

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Historical stock price chart and annual return over the past years

-97%

5 years

% Total

CAMP
-50%

5 years

Annual Return

CAMP